-
Most Popular
RAD
Pfizer Spares Patients From Erectile Dysfunction Embarrassment
Pfizer has created an industry first by selling its successful Viagra pill directly to consumers -- a move that has implications for major drugmakers and pharmacies alike.
Tech, Banks Continue to Slide — Thursday’s IP Market Recap
Markets fell broadly for a second straight day on the heels of unimpressive earnings reports, and a selloff in tech and bank stocks
Should I Buy Rite Aid? 3 Pros, 3 Cons
Rite Aid's turnaround continues to gain traction, but does that make it a solid investment? Decide by looking at RAD's pros and cons.
Tech Can’t Stop the Rally — Thursday’s IP Market Recap
Technology stocks reversed course as a report showed dramatic slippage in PC shipments, but the Dow and S&P still marched on to new records.
Day Five, Still Alive! — Monday’s IP Market Recap
The Dow Jones set a new high for a fifth-straight day and the S&P 500 edged closer to its all-time peak as investors absorbed good news on the corporate front.
5 Stocks to Clean Out of Your Attic — Now
Hint: The stocks you should sell today are the stocks you should have sold yesterday, or long before. Don't wait any longer.
Flu’s Pain Is All Gain for These Companies
As this year's flu season intensifies, so do the profits for some businesses such as vaccine makers, pharmacies and even certain food and beverage makers.
Walgreen Still a Long Term Dividend Player
Walgreen has provided investors with dividend increases for 37 years in a row and despite competition should prove to be a strong long term player
All Earnings, All the Time — Thursday’s IP Market Recap
Tech stocks ruled the day as strong earnings in the sector and across the board helped lift markets to gains Thursday.
3 Reasons to Flee Walgreen
The market is worried that Walgreen is still struggling to fill the right prescription at the right time. Here are three signs that spell trouble for WAG shares.
10 Recent Economic Warning Flares
While it hasn't been all that bad of a June, there are still plenty of reasons to be cautious -- at both national and corporate levels. Here are 10 recent red flags.
A Great Day Above the Surface — Tuesday’s IP Market Recap
Microsoft's Surface announcement buoyed tech stocks and banks floated higher on Fed hopes, helping the broader markets to another day in the black.
Walgreen No Longer Fills the Prescription
Walgreen's earnings and revenues are under pressure after they gave up a relationship with Express Script's in 2011. Look to sell Walgreen.
Which Is Healthier, CVS or Walgreen?
WAG lags after the loss of Express Scripts, but acquiring Rite Aid could restore its health.
Ready, Set, Go for Earnings Season
Earnings season is now in full swing, with Alcoa kicking things off on the right foot by beating Wall Street estimates.
Trade E-Books Find Their Way
Will mass-market trade paperbacks be supplanted by their e-book cousins? Sale figures suggest the shift is well under way.
Best Drug Stores for Customer Satisfaction
Fourth-quarter results of the American Customer Satisfaction Index show a preference for smaller drug stores over large chains.
